Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: A phase 2 study.

Results of a Phase II trial with weekly administration of TCF and concurrent radiotherapy

Titolo:	Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: A phase 2 study.
Autori:	PASINI, Felice DE MANZONI, Giovanni Zanoni A Grandinetti A Capirci C Pavarana M Tomezzoli A Rubello D CORDIANO, Claudio mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2013
Rivista:	CANCER
Abstract:	Results of a Phase II trial with weekly administration of TCF and concurrent radiotherapy
Handle:	http://hdl.handle.net/11562/523352
Appare nelle tipologie:	01.01 Articolo in Rivista

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11562/523352

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CATALOGO DEI PRODOTTI DELLA RICERCA